- Home
- AURA vs FTW Comparison
AURA vs FTW Comparison
Compare AURA & FTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.28
Company Overview
Basic Information| Metric | AURA | FTW |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.8M | 465.8M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | AURA | FTW |
|---|---|---|
| Price | $5.28 | $10.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.20 | N/A |
| AVG Volume (30 Days) | ★ 178.6K | N/A |
| Earning Date | 11-13-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.35 | N/A |
| 52 Week High | $8.60 | N/A |
Technical Indicators
Market Signals| Indicator | AURA | FTW |
|---|---|---|
| Relative Strength Index (RSI) | 32.59 | N/A |
| Support Level | $5.30 | N/A |
| Resistance Level | $6.34 | N/A |
| Average True Range (ATR) | 0.36 | 0.00 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 5.00 | 0.00 |
Price Performance
Historical Comparison AURA
FTW
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.